Related Experiment Video
Updated: Sep 13, 2025

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Improving Ethnic Diversity in Cancer Trials Through Healthcare Interpreter Training
Suzanne J Grant1, Mayra Ouriques2, Abhijit Pal3,4,5
1NICM Health Research Institute, Western Sydney University, Penrith South, DC New South Wales, Australia.
Healthcare interpreter training significantly improved knowledge and confidence in cancer clinical trials, addressing a key barrier for culturally and linguistically diverse (CALD) patients. This enhances equitable access to vital cancer research opportunities.
Area of Science:
- Clinical Trials and Oncology Research
- Health Equity and Access
- Medical Interpreting and Communication
Background:
- Patients with cancer from culturally and linguistically diverse (CALD) backgrounds face significant barriers in accessing clinical trials due to language and cultural differences.
- Inequitable access to clinical trials exacerbates cancer outcome disparities for CALD populations and reduces research validity.
- Lack of specialized training for healthcare interpreters (HCIs) in cancer clinical trials terminology is a recognized barrier to patient access.
Purpose of the Study:
- To address the knowledge and skill gaps among HCIs regarding cancer clinical trials.
- To build workforce capacity for interpreters to better serve CALD patients in clinical trial settings.
- To improve the quality of interpreting services for cancer clinical trials.
Main Methods:
- A two-phase quality improvement project involving a baseline knowledge survey and subsequent training modules.
- Phase 1: Subject matter experts and managers co-developed a survey to identify knowledge gaps among approximately 700 NSW HCIs.
- Phase 2: Training modules covering clinical trial concepts, governance, ethics, phases, informed consent, and interpreter roles were delivered; pre- and post-training surveys assessed learning.
Main Results:
- 133 interpreters responded to the initial survey, revealing limited clinical trial interpreting experience (34% never interpreted for a trial) and a mean knowledge accuracy of 68%.
- Key knowledge gaps identified in randomization, trial phases, governance, ethics, and sponsors.
- Post-training, mean knowledge accuracy increased from 74% to 91%, and confidence in understanding terminology rose from 20% to 62% among 92 trained interpreters.
Conclusions:
- Training significantly improved HCIs' knowledge and confidence in cancer clinical trial principles and terminology.
- The developed training modules enhance interpreter competency, facilitating better service delivery to CALD individuals in clinical trials.
- Online availability of training modules aims for statewide access; future evaluation should assess the impact on CALD trial participation.
Related Concept Videos
Improving Translational Accuracy
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Treatment Resistant Cancers
Tumor Immunotherapy

